Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongqi Xue

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Clinical and Translational Science|February 20, 2025
Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase Inhibitor: A Translational AnalysisAshley L Lennox, Libo Sun, Fei Huang, et al.
British Journal of Clinical Pharmacology|June 16, 2021
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrationsAshit Trivedi, Cheng-Pang Hsu, Pegah Jafarinasabian, et al.
Journal of Clinical Pharmacology|June 6, 2022
ECG Evaluation as Part of the Clinical Pharmacology Strategy in the Development of New Drugs: A Review of Current Practices and Opportunities Based on Five Case StudiesBorje Darpo, Marie Borin, Georg Ferber, et al.
Journal of Clinical Pharmacology|March 6, 2018
Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc AnalysisMaarten Timmers, Vikash Sinha, Borje Darpo, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 7, 2023
Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT IntervalDiane M Donegan, Rosario Pivonello, Antonio Stigliano, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Clinical and Translational Science|February 20, 2025
Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase Inhibitor: A Translational AnalysisAshley L Lennox, Libo Sun, Fei Huang, et al.
British Journal of Clinical Pharmacology|June 16, 2021
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrationsAshit Trivedi, Cheng-Pang Hsu, Pegah Jafarinasabian, et al.
Journal of Clinical Pharmacology|June 6, 2022
ECG Evaluation as Part of the Clinical Pharmacology Strategy in the Development of New Drugs: A Review of Current Practices and Opportunities Based on Five Case StudiesBorje Darpo, Marie Borin, Georg Ferber, et al.
Journal of Clinical Pharmacology|March 6, 2018
Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc AnalysisMaarten Timmers, Vikash Sinha, Borje Darpo, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 7, 2023
Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT IntervalDiane M Donegan, Rosario Pivonello, Antonio Stigliano, et al.
Pageof 5